Illustration of a person using a katana to slash a coronavirus in half

COVID-19 Immune Response Study Could Lead to More Effective Treatments

Findings from the ISB-Swedish COVID-19 Immune Response Study suggest that treatments aimed at arresting the infection at the stage of moderate severity may be most effective. The team studied 139 patients and found that mild COVID-19 is very distinct from the moderate or severe forms of disease, which appear surprisingly similar. 

COVID-19 Immune Response Study Could Lead to More Effective Treatments
COVID-19 Immune Response Study Could Lead to More Effective Treatments
View of the responsive recruitment website and electronic consent platform as seen on mobile phone and desktop devices.

ISB Builds Digital Platform for COVID-19 Research Study – and Beyond

In a multi-institutional study of a highly infectious disease like COVID-19, paperless consent for study participants is critical. One component of the COVID-19 Immune Response Study is a recruitment website with an IRB-approved and HIPAA-compliant electronic consent platform for enrolling patients.

ISB Builds Digital Platform for COVID-19 Research Study – and Beyond
ISB Builds Digital Platform for COVID-19 Research Study – and Beyond
ISB researchers

Unveiling the Guerrilla Warfare Tactics of Mycobacterium Tuberculosis

ISB researchers have unveiled new insights on how Mycobacterium tuberculosis, the pathogen that causes tuberculosis, enters and exits a dormant state in human hosts. About a quarter of the world’s population has latent TB, so these important findings will enable and accelerate the discovery of more effective TB drugs.

Unveiling the Guerrilla Warfare Tactics of Mycobacterium Tuberculosis
Unveiling the Guerrilla Warfare Tactics of Mycobacterium Tuberculosis
the case for masks

Molecular Biologist Dr. Sui Huang: We Should All Be Wearing Masks

ISB's Dr. Sui Huang has been a powerful voice in a growing chorus contending that masks are an effective tool to stop the spread of COVID-19. Huang calls guidelines from the CDC and other public health agencies “unfortunate,” as they sweep aside a potentially powerful measure that could help “flatten the curve.”

Molecular Biologist Dr. Sui Huang: We Should All Be Wearing Masks
Molecular Biologist Dr. Sui Huang: We Should All Be Wearing Masks
Illustration of a person using a katana to slash a coronavirus in half

Merck, ISB, Swedish Collaborate In Trial to Understand, Treat COVID-19

ISB and Swedish Medical Center launched a study to follow hundreds of patients who contract COVID-19 to learn why those infected have drastically different outcomes. “Each of the COVID-19 patients has a unique lesson to teach us about how the medical and scientific community can respond most effectively to this pandemic,” said ISB President Dr. Jim Heath, who co-leads the study.

Merck, ISB, Swedish Collaborate In Trial to Understand, Treat COVID-19
Merck, ISB, Swedish Collaborate In Trial to Understand, Treat COVID-19
mosquito

Malaria Researchers’ Findings May Have Implications for Preventing Spread of Deadly Disease

ISB researchers and their collaborators are using systems biology approaches to learn how the malaria parasite is able to transfer to humans via the bite of an infected mosquito. The information they have uncovered may help identify new ways to prevent people from contracting the deadly disease.

Malaria Researchers’ Findings May Have Implications for Preventing Spread of Deadly Disease
Malaria Researchers’ Findings May Have Implications for Preventing Spread of Deadly Disease
1 2 3 4 5